aluates Reports

$ 0.0

Automative

Global Biologic Patches Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-16T17135

Global Biologic Patches Market Research Report 2024

BUY CHAPTERS

Global Biologic Patches Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16T17135

Report

November 2025

Pages:156

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Edwards Lifesciences

FOC Medical

Tisgenx

Collagen Solutions

Artivion

Baxter

LeMaitre

W. L. Gore & Associates

Labcor

RTI Surgical (RTI)

W. L. Gore & Associates

Biologic Patches Market

The global Biologic Patches market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Biologic patches, also known as bioprosthetic patches or biological patches, are medical implants used in surgical procedures to repair or reconstruct tissues or organs in the body. Unlike synthetic patches made from materials such as Dacron or polytetrafluoroethylene (PTFE), biologic patches are derived from natural sources, typically animal tissues or human tissue donors. These patches offer several advantages, including biocompatibility, reduced risk of infection, and potential for tissue regeneration and remodeling.

From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Biologic Patches leading manufacturers including Abbott, Edwards Lifesciences, FOC Medical, Tisgenx, Collagen Solutions, Artivion, Baxter, LeMaitre, W. L. Gore & Associates, Labcor, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biologic Patches market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Biologic Patches Market Report

Report Metric	Details
Report Name	Biologic Patches Market
Segment by Type	Porcine Patch Bovine Patch Equine Patch Others
Segment by Application	Hospitals Ambulatory Care Centers Diagnostic Centers Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Edwards Lifesciences, FOC Medical, Tisgenx, Collagen Solutions, Artivion, Baxter, LeMaitre, W. L. Gore & Associates, Labcor, RTI Surgical (RTI)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Biologic Patches study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biologic Patches Market report?

Ans: The main players in the Biologic Patches Market are Abbott, Edwards Lifesciences, FOC Medical, Tisgenx, Collagen Solutions, Artivion, Baxter, LeMaitre, W. L. Gore & Associates, Labcor, RTI Surgical (RTI)

What are the Application segmentation covered in the Biologic Patches Market report?

Ans: The Applications covered in the Biologic Patches Market report are Hospitals, Ambulatory Care Centers, Diagnostic Centers, Others

What are the Type segmentation covered in the Biologic Patches Market report?

Ans: The Types covered in the Biologic Patches Market report are Porcine Patch, Bovine Patch, Equine Patch, Others

1 Study Coverage

1.1 Introduction to Biologic Patches: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Biologic Patches Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Porcine Patch

1.2.3 Bovine Patch

1.2.4 Equine Patch

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Biologic Patches Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Care Centers

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Biologic Patches Revenue Estimates and Forecasts 2020-2031

2.2 Global Biologic Patches Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Biologic Patches Sales Estimates and Forecasts 2020-2031

2.4 Global Biologic Patches Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Biologic Patches Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Biologic Patches Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Porcine Patch Market Size by Manufacturers

3.5.2 Bovine Patch Market Size by Manufacturers

3.5.3 Equine Patch Market Size by Manufacturers

3.5.4 Others Market Size by Manufacturers

3.6 Global Biologic Patches Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Biologic Patches Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Biologic Patches Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Biologic Patches Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Biologic Patches Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Biologic Patches Sales and Revenue by Type (2020-2031)

6.4 North America Biologic Patches Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Biologic Patches Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Biologic Patches Sales and Revenue by Type (2020-2031)

7.4 Europe Biologic Patches Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Biologic Patches Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Biologic Patches Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Biologic Patches Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Biologic Patches Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Biologic Patches Sales and Revenue by Type (2020-2031)

9.4 Central and South America Biologic Patches Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Biologic Patches Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Biologic Patches Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Biologic Patches Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Biologic Patches Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abbott

11.1.1 Abbott Corporation Information

11.1.2 Abbott Business Overview

11.1.3 Abbott Biologic Patches Product Models, Descriptions and Specifications

11.1.4 Abbott Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Abbott Biologic Patches Sales by Product in 2024

11.1.6 Abbott Biologic Patches Sales by Application in 2024

11.1.7 Abbott Biologic Patches Sales by Geographic Area in 2024

11.1.8 Abbott Biologic Patches SWOT Analysis

11.1.9 Abbott Recent Developments

11.2 Edwards Lifesciences

11.2.1 Edwards Lifesciences Corporation Information

11.2.2 Edwards Lifesciences Business Overview

11.2.3 Edwards Lifesciences Biologic Patches Product Models, Descriptions and Specifications

11.2.4 Edwards Lifesciences Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Edwards Lifesciences Biologic Patches Sales by Product in 2024

11.2.6 Edwards Lifesciences Biologic Patches Sales by Application in 2024

11.2.7 Edwards Lifesciences Biologic Patches Sales by Geographic Area in 2024

11.2.8 Edwards Lifesciences Biologic Patches SWOT Analysis

11.2.9 Edwards Lifesciences Recent Developments

11.3 FOC Medical

11.3.1 FOC Medical Corporation Information

11.3.2 FOC Medical Business Overview

11.3.3 FOC Medical Biologic Patches Product Models, Descriptions and Specifications

11.3.4 FOC Medical Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 FOC Medical Biologic Patches Sales by Product in 2024

11.3.6 FOC Medical Biologic Patches Sales by Application in 2024

11.3.7 FOC Medical Biologic Patches Sales by Geographic Area in 2024

11.3.8 FOC Medical Biologic Patches SWOT Analysis

11.3.9 FOC Medical Recent Developments

11.4 Tisgenx

11.4.1 Tisgenx Corporation Information

11.4.2 Tisgenx Business Overview

11.4.3 Tisgenx Biologic Patches Product Models, Descriptions and Specifications

11.4.4 Tisgenx Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Tisgenx Biologic Patches Sales by Product in 2024

11.4.6 Tisgenx Biologic Patches Sales by Application in 2024

11.4.7 Tisgenx Biologic Patches Sales by Geographic Area in 2024

11.4.8 Tisgenx Biologic Patches SWOT Analysis

11.4.9 Tisgenx Recent Developments

11.5 Collagen Solutions

11.5.1 Collagen Solutions Corporation Information

11.5.2 Collagen Solutions Business Overview

11.5.3 Collagen Solutions Biologic Patches Product Models, Descriptions and Specifications

11.5.4 Collagen Solutions Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Collagen Solutions Biologic Patches Sales by Product in 2024

11.5.6 Collagen Solutions Biologic Patches Sales by Application in 2024

11.5.7 Collagen Solutions Biologic Patches Sales by Geographic Area in 2024

11.5.8 Collagen Solutions Biologic Patches SWOT Analysis

11.5.9 Collagen Solutions Recent Developments

11.6 Artivion

11.6.1 Artivion Corporation Information

11.6.2 Artivion Business Overview

11.6.3 Artivion Biologic Patches Product Models, Descriptions and Specifications

11.6.4 Artivion Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Artivion Recent Developments

11.7 Baxter

11.7.1 Baxter Corporation Information

11.7.2 Baxter Business Overview

11.7.3 Baxter Biologic Patches Product Models, Descriptions and Specifications

11.7.4 Baxter Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Baxter Recent Developments

11.8 LeMaitre

11.8.1 LeMaitre Corporation Information

11.8.2 LeMaitre Business Overview

11.8.3 LeMaitre Biologic Patches Product Models, Descriptions and Specifications

11.8.4 LeMaitre Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 LeMaitre Recent Developments

11.9 W. L. Gore & Associates

11.9.1 W. L. Gore & Associates Corporation Information

11.9.2 W. L. Gore & Associates Business Overview

11.9.3 W. L. Gore & Associates Biologic Patches Product Models, Descriptions and Specifications

11.9.4 W. L. Gore & Associates Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 W. L. Gore & Associates Recent Developments

11.10 Labcor

11.10.1 Labcor Corporation Information

11.10.2 Labcor Business Overview

11.10.3 Labcor Biologic Patches Product Models, Descriptions and Specifications

11.10.4 Labcor Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Labcor Recent Developments

11.11 RTI Surgical (RTI)

11.11.1 RTI Surgical (RTI) Corporation Information

11.11.2 RTI Surgical (RTI) Business Overview

11.11.3 RTI Surgical (RTI) Biologic Patches Product Models, Descriptions and Specifications

11.11.4 RTI Surgical (RTI) Biologic Patches Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 RTI Surgical (RTI) Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Biologic Patches Industry Chain

12.2 Biologic Patches Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Biologic Patches Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Biologic Patches Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Biologic Patches Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Biologic Patches Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Abbott

Edwards Lifesciences

FOC Medical

Tisgenx

Collagen Solutions

Artivion

Baxter

LeMaitre

W. L. Gore & Associates

Labcor

RTI Surgical (RTI)

W. L. Gore & Associates

List of Tables

Table 1. Global Biologic Patches Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Biologic Patches Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Biologic Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Biologic Patches Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Biologic Patches Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Biologic Patches Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Pcs)

Table 7. Global Biologic Patches Sales by Region (2020-2025) & (K Pcs)

Table 8. Global Biologic Patches Sales by Region (2026-2031) & (K Pcs)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Biologic Patches Sales by Manufacturers (2020-2025) & (K Pcs)

Table 11. Global Biologic Patches Sales Share by Manufacturers (2020-2025)

Table 12. Global Biologic Patches Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Biologic Patches Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Biologic Patches by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Patches as of 2024)

Table 16. Global Biologic Patches Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Biologic Patches Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Pc)

Table 18. Key Manufacturers Biologic Patches Manufacturing Base and Headquarters

Table 19. Global Biologic Patches Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Biologic Patches Sales by Type (2020-2025) & (K Pcs)

Table 23. Global Biologic Patches Sales by Type (2026-2031) & (K Pcs)

Table 24. Global Biologic Patches Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Biologic Patches Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Biologic Patches ASP by Type (2020-2031) & (US$/Pc)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Biologic Patches Sales by Application (2020-2025) & (K Pcs)

Table 29. Global Biologic Patches Sales by Application (2026-2031) & (K Pcs)

Table 30. Biologic Patches High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Biologic Patches Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Biologic Patches Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Biologic Patches ASP by Application (2020-2031) & (US$/Pc)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Biologic Patches Growth Accelerators and Market Barriers

Table 37. North America Biologic Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Biologic Patches Sales (K Pcs) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Biologic Patches Growth Accelerators and Market Barriers

Table 40. Europe Biologic Patches Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Biologic Patches Sales (K Pcs) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Biologic Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Biologic Patches Sales (K Pcs) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Biologic Patches Growth Accelerators and Market Barriers

Table 45. Southeast Asia Biologic Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Biologic Patches Investment Opportunities and Key Challenges

Table 47. Central and South America Biologic Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Biologic Patches Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Biologic Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Abbott Corporation Information

Table 51. Abbott Description and Major Businesses

Table 52. Abbott Product Models, Descriptions and Specifications

Table 53. Abbott Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 54. Abbott Sales Value Proportion by Product in 2024

Table 55. Abbott Sales Value Proportion by Application in 2024

Table 56. Abbott Sales Value Proportion by Geographic Area in 2024

Table 57. Abbott Biologic Patches SWOT Analysis

Table 58. Abbott Recent Developments

Table 59. Edwards Lifesciences Corporation Information

Table 60. Edwards Lifesciences Description and Major Businesses

Table 61. Edwards Lifesciences Product Models, Descriptions and Specifications

Table 62. Edwards Lifesciences Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 63. Edwards Lifesciences Sales Value Proportion by Product in 2024

Table 64. Edwards Lifesciences Sales Value Proportion by Application in 2024

Table 65. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024

Table 66. Edwards Lifesciences Biologic Patches SWOT Analysis

Table 67. Edwards Lifesciences Recent Developments

Table 68. FOC Medical Corporation Information

Table 69. FOC Medical Description and Major Businesses

Table 70. FOC Medical Product Models, Descriptions and Specifications

Table 71. FOC Medical Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 72. FOC Medical Sales Value Proportion by Product in 2024

Table 73. FOC Medical Sales Value Proportion by Application in 2024

Table 74. FOC Medical Sales Value Proportion by Geographic Area in 2024

Table 75. FOC Medical Biologic Patches SWOT Analysis

Table 76. FOC Medical Recent Developments

Table 77. Tisgenx Corporation Information

Table 78. Tisgenx Description and Major Businesses

Table 79. Tisgenx Product Models, Descriptions and Specifications

Table 80. Tisgenx Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 81. Tisgenx Sales Value Proportion by Product in 2024

Table 82. Tisgenx Sales Value Proportion by Application in 2024

Table 83. Tisgenx Sales Value Proportion by Geographic Area in 2024

Table 84. Tisgenx Biologic Patches SWOT Analysis

Table 85. Tisgenx Recent Developments

Table 86. Collagen Solutions Corporation Information

Table 87. Collagen Solutions Description and Major Businesses

Table 88. Collagen Solutions Product Models, Descriptions and Specifications

Table 89. Collagen Solutions Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 90. Collagen Solutions Sales Value Proportion by Product in 2024

Table 91. Collagen Solutions Sales Value Proportion by Application in 2024

Table 92. Collagen Solutions Sales Value Proportion by Geographic Area in 2024

Table 93. Collagen Solutions Biologic Patches SWOT Analysis

Table 94. Collagen Solutions Recent Developments

Table 95. Artivion Corporation Information

Table 96. Artivion Description and Major Businesses

Table 97. Artivion Product Models, Descriptions and Specifications

Table 98. Artivion Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 99. Artivion Recent Developments

Table 100. Baxter Corporation Information

Table 101. Baxter Description and Major Businesses

Table 102. Baxter Product Models, Descriptions and Specifications

Table 103. Baxter Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 104. Baxter Recent Developments

Table 105. LeMaitre Corporation Information

Table 106. LeMaitre Description and Major Businesses

Table 107. LeMaitre Product Models, Descriptions and Specifications

Table 108. LeMaitre Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 109. LeMaitre Recent Developments

Table 110. W. L. Gore & Associates Corporation Information

Table 111. W. L. Gore & Associates Description and Major Businesses

Table 112. W. L. Gore & Associates Product Models, Descriptions and Specifications

Table 113. W. L. Gore & Associates Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 114. W. L. Gore & Associates Recent Developments

Table 115. Labcor Corporation Information

Table 116. Labcor Description and Major Businesses

Table 117. Labcor Product Models, Descriptions and Specifications

Table 118. Labcor Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 119. Labcor Recent Developments

Table 120. RTI Surgical (RTI) Corporation Information

Table 121. RTI Surgical (RTI) Description and Major Businesses

Table 122. RTI Surgical (RTI) Product Models, Descriptions and Specifications

Table 123. RTI Surgical (RTI) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2020-2025)

Table 124. RTI Surgical (RTI) Recent Developments

Table 125. Key Raw Materials Distribution

Table 126. Raw Materials Key Suppliers

Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 128. Milestones in Production Technology Evolution

Table 129. Distributors List

Table 130. Market Trends and Market Evolution

Table 131. Market Drivers and Opportunities

Table 132. Market Challenges, Risks, and Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Biologic Patches Product Picture

Figure 2. Global Biologic Patches Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Porcine Patch Product Picture

Figure 4. Bovine Patch Product Picture

Figure 5. Equine Patch Product Picture

Figure 6. Others Product Picture

Figure 7. Global Biologic Patches Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Hospitals

Figure 9. Ambulatory Care Centers

Figure 10. Diagnostic Centers

Figure 11. Others

Figure 12. Biologic Patches Report Years Considered

Figure 13. Global Biologic Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 15. Global Biologic Patches Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Biologic Patches Revenue Market Share by Region (2020-2031)

Figure 17. Global Biologic Patches Sales (2020-2031) & (K Pcs)

Figure 18. Global Biologic Patches Sales (CAGR) by Region (2020-2031) (K Pcs)

Figure 19. Global Biologic Patches Sales Market Share by Region (2020-2031)

Figure 20. Top 5 and Top 10 Manufacturers Biologic Patches Sales Volume Market Share in 2024

Figure 21. Global Biologic Patches Revenue Market Share Ranking (2024)

Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 23. Porcine Patch Revenue Market Share by Manufacturer in 2024

Figure 24. Bovine Patch Revenue Market Share by Manufacturer in 2024

Figure 25. Equine Patch Revenue Market Share by Manufacturer in 2024

Figure 26. Others Revenue Market Share by Manufacturer in 2024

Figure 27. Global Biologic Patches Sales Market Share by Type (2020-2031)

Figure 28. Global Biologic Patches Revenue Market Share by Type (2020-2031)

Figure 29. Global Biologic Patches Sales Market Share by Application (2020-2031)

Figure 30. Global Biologic Patches Revenue Market Share by Application (2020-2031)

Figure 31. North America Biologic Patches Sales YoY (2020-2031) & (K Pcs)

Figure 32. North America Biologic Patches Revenue YoY (2020-2031) & (US$ Million)

Figure 33. North America Top 5 Manufacturers Biologic Patches Sales Revenue (US$ Million) in 2024

Figure 34. North America Biologic Patches Sales Volume (K Pcs) by Type (2020- 2031)

Figure 35. North America Biologic Patches Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 36. North America Biologic Patches Sales Volume (K Pcs) by Application (2020-2031)

Figure 37. North America Biologic Patches Sales Revenue (US$ Million) by Application (2020-2031)

Figure 38. US Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 39. Canada Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 40. Mexico Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 41. Europe Biologic Patches Sales YoY (2020-2031) & (K Pcs)

Figure 42. Europe Biologic Patches Revenue YoY (2020-2031) & (US$ Million)

Figure 43. Europe Top 5 Manufacturers Biologic Patches Sales Revenue (US$ Million) in 2024

Figure 44. Europe Biologic Patches Sales Volume (K Pcs) by Type (2020-2031)

Figure 45. Europe Biologic Patches Sales Revenue (US$ Million) by Type (2020-2031)

Figure 46. Europe Biologic Patches Sales Volume (K Pcs) by Application (2020-2031)

Figure 47. Europe Biologic Patches Sales Revenue (US$ Million) by Application (2020-2031)

Figure 48. Germany Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 49. France Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 50. U.K. Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 51. Italy Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 52. Russia Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 53. Asia-Pacific Biologic Patches Sales YoY (2020-2031) & (K Pcs)

Figure 54. Asia-Pacific Biologic Patches Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Asia-Pacific Top 8 Manufacturers Biologic Patches Sales Revenue (US$ Million) in 2024

Figure 56. Asia-Pacific Biologic Patches Sales Volume (K Pcs) by Type (2020- 2031)

Figure 57. Asia-Pacific Biologic Patches Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 58. Asia-Pacific Biologic Patches Sales Volume (K Pcs) by Application (2020-2031)

Figure 59. Asia-Pacific Biologic Patches Sales Revenue (US$ Million) by Application (2020-2031)

Figure 60. Indonesia Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 61. Japan Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 62. South Korea Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 63. China Taiwan Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 64. India Biologic Patches Revenue (2020-2031) & (US$ Million)

Figure 65. Central and South America Biologic Patches Sales YoY (2020-2031) & (K Pcs)

Figure 66. Central and South America Biologic Patches Revenue YoY (2020-2031) & (US$ Million)

Figure 67. Central and South America Top 5 Manufacturers Biologic Patches Sales Revenue (US$ Million) in 2024

Figure 68. Central and South America Biologic Patches Sales Volume (K Pcs) by Type (2021-2031)

Figure 69. Central and South America Biologic Patches Sales Revenue (US$ Million) by Type (2020-2031)

Figure 70. Central and South America Biologic Patches Sales Volume (K Pcs) by Application (2020-2031)

Figure 71. Central and South America Biologic Patches Sales Revenue (US$ Million) by Application (2020-2031)

Figure 72. Brazil Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 73. Argentina Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 74. Middle East, and Africa Biologic Patches Sales YoY (2020-2031) & (K Pcs)

Figure 75. Middle East and Africa Biologic Patches Revenue YoY (2020-2031) & (US$ Million)

Figure 76. Middle East and Africa Top 5 Manufacturers Biologic Patches Sales Revenue (US$ Million) in 2024

Figure 77. Middle East and Africa Biologic Patches Sales Volume (K Pcs) by Type (2021-2031)

Figure 78. South America Biologic Patches Sales Revenue (US$ Million) by Type (2020-2031)

Figure 79. Middle East and Africa Biologic Patches Sales Volume (K Pcs) by Application (2020-2031)

Figure 80. Middle East and Africa Biologic Patches Sales Revenue (US$ Million) by Application (2020-2031)

Figure 81. GCC Countries Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 82. Turkey Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 83. Egypt Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 84. South Africa Biologic Patches Revenue (2020-2025) & (US$ Million)

Figure 85. Biologic Patches Industry Chain Mapping

Figure 86. Regional Biologic Patches Manufacturing Base Distribution (%)

Figure 87. Global Biologic Patches Production Market Share by Region (2020-2031)

Figure 88. Biologic Patches Production Process

Figure 89. Regional Biologic Patches Production Cost Structure

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biologic Vascular Patch Market Research Report 2024

Global Synthetic Bio implants Market Research Report 2024

Global Anal Fistula Patch Market Research Report 2024

Global Pericardial Vascular Patches Market Research Report 2024

Global Hernia Biologic Meshes Market Research Report 2024

Global Absorbable Patch Market Research Report 2025

Global Bovine Pericardial Vascular Patches Market Research Report 2024

Global Animal Derived Dural Patch Market Research Report 2024

Global Biologic Skin Substitutes Market Research Report 2024

Global Fully Synthetic Bio implant Market Research Report 2024

Global Stented Tissue Heart Valve Market Research Report 2024

Global ePTFE Cardiovascular Patch Market Research Report 2025

Global Medical Wound Care Biologics Market Research Report 2025

Global Biologic Hernia Repair Mesh Market Research Report 2024

Global Biosupplements Containing Antibiotics Market Research Report 2024

Global Synthetic Polymer Implants Market Research Report 2024

Global Vascular Patches Market Research Report 2024

Global Medical Dressing Patch Market Research Report 2024

Global PVDF Hernia Patch Market Research Report 2024

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37F12574

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O12834

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36J12622

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions